05:57:46 EDT Sat 18 May 2024
Enter Symbol
or Name
USA
CA



Treatment.com AI Inc
Symbol TRUE
Shares Issued 37,105,115
Close 2024-03-19 C$ 0.60
Market Cap C$ 22,263,069
Recent Sedar Documents

Treatment.com's AI platform passes med school exam

2024-03-20 11:22 ET - News Release

Dr. Essam Hamza reports

TREATMENT AI PASSES MEDICAL SCHOOL CLINICAL EXAM WITH 92% SUCCESS RATE

Treatment.com AI Inc.'s artificial intelligence medical information support platform was used in the Objective Structured Clinical Examination (OSCE), a standard clinical exam of diagnostic aptitude at medical and nursing schools, passing the exam with a 92-per-cent success rate.

Treatment.com gave a third-year non-medical college student the Treatment mobile app and had them join a class of third-year medical school students taking their annual clinical exam. The OSCE exam is a standard exam given at medical, nursing and other professional health care schools. They are integral in medical education, as they allow a student to practice and demonstrate clinical diagnostic skills in an artificial medical scenario. During the exam, students enter an exam room to assess an actor who has been instructed on imitating a patient with a specific disease. Passing the OSCE is a national requirement for graduation in 57 countries worldwide (including the United States, Canada and United Kingdom) for medical and nursing students.

In this case, Treatment.com gave the student its Treatment AI mobile app and sent them in to examine 12 simulated patients. The student used the app to ask the patient questions, then left the room and wrote a clinical note summarizing the findings and suggesting the most likely possible diagnoses. The college student, with no previous medical training, entered the simulated patient's age, sex and initial symptom, and followed the prompts to complete an individualized assessment. The student then used the information summarized by the application to write a medical note describing the history, exam, recommended labs and diagnoses. The student passed the exam, getting 11 of 12 first-most-likely diagnoses correct. This included the student successfully making a variety of complex diagnoses, including colon cancer, appendicitis, acute myocardial infarction, diabetes and patellar tendonitis.

Dr. Kevin Peterson, MD, MPH, chief medical officer, stated: "The ability of the AI software to identify the pertinent positives and negatives, together with physical exam findings, and turn them into a precise description and reasoned differential diagnoses, was remarkable. This is an AI tool that any medical professional can use in their pocket."

Dr. Essam Hamza, MD, chief executive officer of Treatment.com AI, added: "We are extremely excited with the power and accuracy of our AI medical diagnostic engine and the faith medical schools have in utilizing it, for testing and training the medical professionals of tomorrow. This underlying software is also the foundation of new products we are planning to launch in the health care marketplace later this year, in our mission to dramatically disrupt how health care is delivered worldwide"

Treatment.com AI provides solutions for medical education and clinical information support. The medical education suite (MES) provides case-based clinical decision-making testing, grading and remedial action support for the next generation of health care professionals. The goals for MES are to enable better performance for medical school students in their national exams (including OSCE) and for schools, to reduce administration and exam creation costs, as well as minimizing valuable time for faculty in administering and grading exams.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.